- Bupa Platinum consultant
-
Fee assured
-
Verified account
- Open Referral network
Specialises in
- General
- Haemato-oncology
Offers
- Face-to-face consultations
- Video and telephone consultations
About me
Dr Ferguson is a consultant Haematologist working at University Hospitals of Birmingham NHS Trust. He specialises in treating patients with both malignant blood cancers and those with general, benign blood disorders. He has a particular interest in treating patients with myeloma, lymphoma and myeloid malignancies, bone marrow transplantation and CAR T cell therapy.
Dr Ferguson holds a national role as Director of the Midlands and Wales Advanced Therapies Treatment Centres (MW-ATTC) focused on the delivery of next generation, advanced clinical trials and therapies for patients across the region.
He has previously held the post of lead clinician for Haematology at two of the biggest Haematology departments in the West Midlands at University Hospitals Birmingham and University Hospitals of North Midlands NHS Trust. He has a strong interest in cancer diagnostics and has held a leadership position within the West Midlands Cancer Alliance with a focus on faster cancer diagnostic pathways and supported the role out of novel non-site specific cancer diagnostic pathways across the West Midlands.
He is strongly patient focused and dedicated to delivering the best in patient care.
Dr Ferguson graduated in medicine with honours from the University of Birmingham having previously attained a first class honours degree in Biomedical Science and a PhD in Cancer research with a focus on molecular biology.
His haematology training was principally based at the Queen Elizabeth hospital in Birmingham. During this time he was appointed as an academic clinical lecturer and aligned clinical commitments with clinical research. His areas for research were the delivery of early phase clinical trials, bone marrow transplantation and basic scientific research into the genetics of acute myeloid leukaemia which he undertook at Oxford University and the University of Birmingham. He is an author on a number of high impact clinical research publications and has received a national award for his research.
He is a member of the Royal College of Physicians and a Fellow of the Royal College of Pathologists.
Areas of interest
General benign haematological disorders; Blood testing and interpretation; Abnormal blood results; Myeloma; Lymphoma; Chronic Lymphocytic leukaemia;Chronic Myeloid Leukaemia; Waldenstrom Macroglobulinaemia; Esstential Thrombocythaemia; Polycythaemamia; Haemachromatosis; Myeloproliferative neoplasms; Myelodysplastic Syndrome; Anaemia; Iron deficiency; Iron overload; B12 Deficiency; Neutropenia; Lymphopenia; Enlarged lymph nodes; Paraproteinaemia/MGUS; Bone marrow biopsy; Intravenous Iron infusions; Venesections; Immunotherapy; Chemotherapy; Bone marrow transplantation; CAR T cell therapy;
Medical secretaries
- Jill Ryles
- 07415 190804
- jill.ryles@nhs.net
Information for healthcare professionals (Bupa patients only, last 12 months)
-
X0004
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-28 days - (>50)
-
X0003
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-21 days - (5-50)
-
W3650
Diagnostic aspiration and trephine biopsy of bone marrow, including analysis - (1-5)
Nuffield Health Wolverhampton Hospital (1-5) HCA Healthcare UK The Harborne Hospital (1-5)